The neural cell adhesion molecule binds to fibroblast growth factor receptor 2

被引:56
作者
Christensen, Claus [1 ]
Lauridsen, Jes B. [1 ]
Berezin, Vladimir [1 ]
Bock, Elisabeth [1 ]
Kiselyov, Vladislav V. [1 ]
机构
[1] Univ Copenhagen, Prot Lab, DK-2200 Copenhagen, Denmark
来源
FEBS LETTERS | 2006年 / 580卷 / 14期
关键词
neural cell adhesion molecule; fibroblast growth factor receptor; binding; interaction; surface plasmon resonance;
D O I
10.1016/j.febslet.2006.05.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neural cell adhesion molecule (NCAM) can bind to and activate fibroblast growth factor receptor 1 (FGFR1). However, there are four major FGFR isoforms (FGFR1-FGFR4), and it is not known whether NCAM also interacts directly with the other three FGFR isoforms. In this study, we show by surface plasmon resonance analysis that NCAM can bind to FGFR2 with an affinity similar to that for the NCAM-FGFR1 interaction. However, the kinetic parameters for the NCAM-FGFR2 binding are different from those of the NCAM-FGFR1 binding. Both receptors were shown to cycle relatively fast between the NCAM bound and unbound states, although FGFR2 cycling was clearly faster (13 times) than the FGFR1 cycling. Moreover, ATP was more effective in inhibiting the binding of NCAM to FGFR1 than to FGFR2, indicating that the binding sites in NCAM for the two receptors are similar, but not identical. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3386 / 3390
页数:5
相关论文
共 11 条
  • [1] Berezin V, 2000, Curr Opin Drug Discov Devel, V3, P605
  • [2] Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
    Ibrahimi, OA
    Zhang, FM
    Eliseenkova, AV
    Itoh, N
    Linhardt, RJ
    Mohammadi, M
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (19) : 2313 - 2324
  • [3] Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly
    Ibrahimi, OA
    Zhang, FM
    Hrstka, SCL
    Mohammadi, M
    Linhardt, RJ
    [J]. BIOCHEMISTRY, 2004, 43 (16) : 4724 - 4730
  • [4] JONSON DE, 1993, ADV CANCER RES, V60, P1
  • [5] Structural biology of NCAM homophilic binding and activation of FGFR
    Kiselyov, VV
    Soroka, V
    Berezin, V
    Bock, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 94 (05) : 1169 - 1179
  • [6] Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP
    Kiselyov, VV
    Skladchikova, G
    Hinsby, AM
    Jensen, PH
    Kulahin, N
    Soroka, V
    Pedersen, N
    Tsetlin, V
    Poulsen, FM
    Berezin, V
    Bock, E
    [J]. STRUCTURE, 2003, 11 (06) : 691 - 701
  • [7] An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons
    Neiiendam, JL
    Kohler, LB
    Christensen, C
    Li, SZ
    Pedersen, MV
    Ditlevsen, DK
    Kornum, MK
    Kiselyov, VV
    Berezin, V
    Bock, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 91 (04) : 920 - 935
  • [8] A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo
    Skibo, GG
    Lushnikova, IV
    Voronin, KY
    Dmitrieva, O
    Novikova, T
    Klementiev, B
    Vaudano, E
    Berezin, VA
    Bock, E
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (07) : 1589 - 1596
  • [9] A SEQUENCE MOTIF IN THE TRANSMEMBRANE REGION OF GROWTH-FACTOR RECEPTORS WITH TYROSINE KINASE-ACTIVITY MEDIATES DIMERIZATION
    STERNBERG, MJE
    GULLICK, WJ
    [J]. PROTEIN ENGINEERING, 1990, 3 (04): : 245 - 248
  • [10] Zippers make signals: NCAM-mediated molecular interactions and signal transduction
    Walmod, PS
    Kolkova, K
    Berezin, V
    Bock, E
    [J]. NEUROCHEMICAL RESEARCH, 2004, 29 (11) : 2015 - 2035